Home
/
Clearside Biomedical, Inc.
/
Financials
/
Quarterly
Clearside Biomedical, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Clearside Biomedical, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$201.0K
Nov 14, 2025
Q2
2025
Jun 30, 2025
$492.0K
Aug 8, 2025
Q1
2025
Mar 31, 2025
$2.33M
May 15, 2025
Q3
2025
Sep 30, 2024
$1.04M
Nov 14, 2025
Q2
2025
Jun 30, 2024
$90.0K
Aug 8, 2025
Q1
2025
Mar 31, 2024
$230.0K
May 15, 2025
Q3
2024
Sep 30, 2023
$859.0K
Nov 12, 2024
Q2
2024
Jun 30, 2023
$1.02M
Aug 12, 2024
Q1
2024
Mar 31, 2023
$4.0K
May 10, 2024
Q3
2023
Sep 30, 2022
$266.0K
Nov 13, 2023
Q2
2023
Jun 30, 2022
$384.0K
Aug 14, 2023
Q1
2023
Mar 31, 2022
$347.0K
May 12, 2023
Q3
2022
Sep 30, 2021
$3.07M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$780.0K
Aug 12, 2022
Q1
2022
Mar 31, 2021
$34.0K
May 12, 2022
Q3
2021
Sep 30, 2020
$3.43M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$354.0K
Aug 10, 2021
Q1
2021
Mar 31, 2020
$4.10M
May 17, 2021
Q3
2020
Sep 30, 2019
$141.0K
Nov 10, 2020
Q2
2020
Jun 30, 2019
$45.0K
Aug 10, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($5.97M)
Nov 14, 2025
Q3
2025
Jun 30, 2025
($4.50M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($4.50M)
Aug 8, 2025
Q2
2025
Mar 31, 2025
($8.22M)
Aug 8, 2025
Q3
2025
Mar 31, 2025
($8.22M)
Nov 14, 2025
Q1
2025
Mar 31, 2025
($8.22M)
May 15, 2025
Q3
2025
Sep 30, 2024
($7.69M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($7.59M)
Aug 8, 2025
Q3
2025
Jun 30, 2024
($7.60M)
Nov 14, 2025
Q2
2025
Mar 31, 2024
($11.76M)
Aug 8, 2025
Q3
2025
Mar 31, 2024
($11.76M)
Nov 14, 2025
Q1
2025
Mar 31, 2024
($11.76M)
May 15, 2025
Q3
2024
Sep 30, 2023
($9.27M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($9.11M)
Aug 12, 2024
Q3
2024
Jun 30, 2023
($9.11M)
Nov 12, 2024
Q2
2024
Mar 31, 2023
($9.28M)
Aug 12, 2024
Q3
2024
Mar 31, 2023
($9.28M)
Nov 12, 2024
Q1
2024
Mar 31, 2023
($9.28M)
May 10, 2024
Q3
2023
Sep 30, 2022
($7.83M)
Nov 13, 2023
Q3
2023
Jun 30, 2022
($7.81M)
Nov 13, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.04M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($3.57M)
Aug 8, 2025
Q1
2025
Mar 31, 2025
($5.21M)
May 15, 2025
Q3
2025
Sep 30, 2024
($5.93M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($7.59M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($8.21M)
May 15, 2025
Q3
2024
Sep 30, 2023
($7.05M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($7.27M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($7.61M)
May 10, 2024
Q3
2023
Sep 30, 2022
($6.72M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($7.84M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($7.65M)
May 12, 2023
Q3
2022
Sep 30, 2021
($4.89M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($6.10M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($8.35M)
May 12, 2022
Q3
2021
Sep 30, 2020
($2.43M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($5.56M)
Aug 10, 2021
Q1
2021
Mar 31, 2020
($2.84M)
May 17, 2021
Q3
2020
Sep 30, 2019
($6.37M)
Nov 10, 2020
Q2
2020
Jun 30, 2019
($5.62M)
Aug 10, 2020